Gastroprotective Agent Compliance in Patients at Risk Suffering From a

See also
Status	Clinical Trial	Phase
Completed	`NCT02903017` - Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage	Phase 4
Recruiting	`NCT02514304` - Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding
Completed	`NCT02384122` - Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias	Phase 3
Completed	`NCT01477320` - Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.	N/A
Not yet recruiting	`NCT01549418` - The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking Aspirin	Phase 4
Completed	`NCT02105532` - Transfusion in Gastrointestinal Bleeding	Phase 2/Phase 3
Recruiting	`NCT05226221` - Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality
Active, not recruiting	`NCT02874326` - Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber	Phase 2
Completed	`NCT02928939` - Therapeutic Conflicts and Multimorbidity
Completed	`NCT01029626` - Glasgow-Blatschford Score Validation in Digestive Hemorrhage	N/A
Completed	`NCT00251979` - A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer	Phase 3
Completed	`NCT02991612` - Rifaximin in Patients With Gastroesophageal Variceal Bleeding	N/A
Recruiting	`NCT02964195` - Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding	N/A
Terminated	`NCT02609100` - Video Capsule Endoscopy Versus Colonoscopy in Patients With Melena and Negative Upper Endoscopy	N/A
Completed	`NCT02965209` - European Novel Motorized Spiral Endoscopy Trial	N/A
Completed	`NCT01872286` - Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2	N/A
Completed	`NCT02349490` - Seraseal for Endoscopic Hemostasis	Phase 4
Withdrawn	`NCT01005147` - Effect of Tranexamic Acid in Upper Gastrointestinal Bleeding	N/A
Completed	`NCT00570973` - Band Ligation Versus Transjugular Intrahepatic Portosystemic Stent Shunt (TIPS) in Cirrhotics With Recurrent Variceal Bleeding Non Responding to Medical Therapy	Phase 4
Completed	`NCT00450164` - Secondary Prophylaxis After Variceal Bleeding in Non-Responders	Phase 4

NCT number	NCT01215058
Study type	Observational
Source	AstraZeneca
Contact
Status	Withdrawn
Phase	N/A
Start date	October 2010
Completion date	April 2011

Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms